{"mainPropery":{"diseaseId":10452,"diseaseName":"Hepatic encephalopathy","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10452/hepatic-encephalopathy","synonyms":["Hepatoencephalopathy","Encephalopathy, hepatic"],"synonyms-with-source":[{"name":"Hepatoencephalopathy"},{"name":"Encephalopathy, hepatic"}],"identifiers":[{"identifierType":"UMLS","identifierId":"C0019151"}]},"diseaseCategories":[{"diseaseTypeId":6,"diseaseTypeName":"Digestive Diseases"}],"organizations":[{"resourceID":942,"resourceName":"American Association for the Study of Liver Diseases","abbreviation":"","address1":"1001 North Fairfax, 4th floor","address2":"","address3":"","address4":"","address5":"","city":"Alexandria","state":"VA","zip":"22314","country":"United States","phone":"703–299–9766","tty":"","tollFree":"","fax":"703–299–9622","email":"aasld@aasld.org","url":"http://www.aasld.org/","freeText":""},{"resourceID":943,"resourceName":"American Liver Foundation","abbreviation":"","address1":"39 Broadway, Suite 2700","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10006","country":"United States","phone":"+1-212-668-1000","tty":"","tollFree":"+1-800-465-4837 (Helpline)","fax":"","email":"https://liverfoundation.org/for-patients/contact-us/","url":"https://liverfoundation.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%28hepatic%5BTitle%5D%20AND%20encephalopathy%5BTitle%5D%29%20AND%20%28%22humans%22%5BMeSH%20Terms%5D%20AND%20English%5Blang%5D%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Hepatic encephalopathy. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Hepatic+encephalopathy%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Hepatic encephalopathy. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":392,"resourceId":1207,"resourceName":"Hepatitis C Support Project (HCSP)","descriptionText":"The <a href='http://www.hcvadvocate.org/index.asp ' target='_blank'>Hepatitis C Support Project (HCSP)</a> is a registered non-profit organization founded to address the lack of education, support, and services available at that time for the HCV population. HCSP's mission is to provide unbiased information, support, and advocacy to all communities affected by HCV and HIV/HCV coinfection, including medical providers. To see their Fact Sheet about hepatic encephalopathy, <a href='http://www.hcvadvocate.org/hepatitis/hepC/hepatic_encephalopathy.html ' target='_blank'>click here</a>.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Organizations Supporting this Disease"},{"id":393,"resourceId":1208,"resourceName":"International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN)","descriptionText":"<a href='http://ishen.org/index.html ' target='_blank'>International Society for Hepatic Encephalopathy and Nitrogen Metabolism</a> (ISHEN) is a non-profit organization aimed at promoting scientific and clinical research on nitrogen metabolism and brain disorders associated with liver disease.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1076,"resourceId":1757,"resourceName":"Hepatic encephalopathy","descriptionText":"<a href='http://www.hepatitis.va.gov/patient/complications/cirrhosis/encephalopathy.asp' target='_blank'>The Department of Veterans Affairs</a> posts information discussed during a talk on hepatic encephalopathy given at the 2004 Advanced Liver Disease Training Program held in Manhattan, New York, from April 12 to 14, and sponsored by the VA Hepatitis C Resource Center Program and Hepatitis C Program Office. To view the presentation, click on the link.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://rarediseases.org/rare-diseases/hepatic-encephalopathy/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/000302.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/186101-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merckmanuals.com/home/sec10/ch135/ch135f.html' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1566,"resourceId":2187,"resourceName":"National Institute on Alcohol Abuse and Alcoholism","descriptionText":"The <a href='http://pubs.niaaa.nih.gov/publications/arh27-3/240-246.htm' target='_blank'>National Institute on Alcohol Abuse and Alcoholism</a> (NIAAA) conducts research focused on improving the treatment and prevention of alcoholism and alcohol-related problems to reduce the enormous health, social, and economic consequences of this disease. Click on the link to view information on this topic. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:13413' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":3994,"questionText":"What is hepatic encephalopathy?","answerText":"<strong>Hepatic encephalopathy</strong> is a syndrome observed in some patients with cirrhosis. It is defined as a spectrum of <a href=\"http://www.merriam-webster.com/medlineplus/neuropsychiatric\" target=\"_blank\">neuropsychiatric</a> abnormalities in patients with liver dysfunction, when other known brain disease has been excluded.[2934]&nbsp;Signs and symptoms&nbsp;may be debilitating, and they can begin mildly and gradually, or occur suddenly and severely.[2935] They may include&nbsp;personality or mood&nbsp;changes, intellectual impairment, abnormal movements,&nbsp;a depressed level of consciousness, and other symptoms.[2934][2935]&nbsp;There are several theories regarding the exact cause, but&nbsp;development of the condition is&nbsp;probably&nbsp;at least partially&nbsp;due to the effect of substances that are toxic to nerve tissue (neurotoxic), which are typically present with liver damage and/or <a href=\"http://www.nlm.nih.gov/medlineplus/liverdiseases.html\" target=\"_blank\">liver disease</a>. Treatment depends upon the severity of mental status changes and upon the certainty of the diagnosis.[2934]","dateModified":"2016-06-22T00:00:00"},"basicQuestions":[{"questionId":3995,"questionText":"Is hepatic encephalopathy inherited?","answerText":"Hepatic encephalopathy is <strong>not</strong> an inherited condition, so an individual who has it cannot pass it on to his/her children. It is brought on by chronic liver failure, particularly in alcoholics with cirrhosis.[2937]<br />\r\n<br />\r\nAlthough there are many theories and possibilities regarding what exactly causes hepatic encephalopathy, it is thought that one of the main causes is&nbsp;the accumulation of ammonia in the blood, which the liver, damaged by alcoholic liver disease, cannot remove.&nbsp;Researchers have found that ammonia alters the <em>expression</em> of certain genes; the genes that may be affected&nbsp;carry instructions&nbsp;for brain proteins.[2937] When the instructions in these genes are not \"followed\" correctly by the body due to the altered expression of the genes, the cells in the brain can no longer function normally, which may contribute to the signs and symptoms of the disease. However, the genes themselves are <strong>not</strong> changed in such a way that these changes are passed down to an individual's children.","dateModified":"2016-06-22T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":2937,"authors":"Roger F. Butterworth","articleTitle":"Hepatic Encephalopathy","bookWebsiteJournalTitle":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","date":"September 29, 2004","volume":"","pages":"","url":"http://pubs.niaaa.nih.gov/publications/arh27-3/240-246.htm","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":29223,"abbreviatedInquiry":"How was hepatic encephalopathy discovered, and who first described it? Is there a chance of passing&nbsp;this condition&nbsp;along to my children?","caseQuestions":[{"questionId":4000,"questionText":"Who first described hepatic encephalopathy?","answerText":"The association between liver disease and mental disorders has been recognized since the time of Hippocrates. Galen,&nbsp;a Roman physician of the 2nd century, described neurologic and psychiatric symptoms resulting from brain diseases and from diseases of other organs, including the liver. Morgagni, the father of pathologic anatomy, described the relation between liver failure and mental disorder in the 18th century. In one of his case reports, Morgagni described an alcoholic man with a history of abdominal pain and delirium who died in coma. Autopsy showed liver cirrhosis, but the brain was grossly normal. Further studies of hepatic encephalopathy continued in the 19th century. The works in which the modern concepts of hepatic encephalopathy are based were published in the 1950s.[2944]","dateModified":"2016-06-22T00:00:00","references":[{"referenceId":2944,"authors":"K K Jain","articleTitle":"Hepatic encephalopathy","bookWebsiteJournalTitle":"Medlink","date":"July 3, 2015","volume":"","pages":"","url":"http://www.medlink.com/article/hepatic_encephalopathy","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3995,"questionText":"Is hepatic encephalopathy inherited?","answerText":"Hepatic encephalopathy is <strong>not</strong> an inherited condition, so an individual who has it cannot pass it on to his/her children. It is brought on by chronic liver failure, particularly in alcoholics with cirrhosis.[2937]<br />\r\n<br />\r\nAlthough there are many theories and possibilities regarding what exactly causes hepatic encephalopathy, it is thought that one of the main causes is&nbsp;the accumulation of ammonia in the blood, which the liver, damaged by alcoholic liver disease, cannot remove.&nbsp;Researchers have found that ammonia alters the <em>expression</em> of certain genes; the genes that may be affected&nbsp;carry instructions&nbsp;for brain proteins.[2937] When the instructions in these genes are not \"followed\" correctly by the body due to the altered expression of the genes, the cells in the brain can no longer function normally, which may contribute to the signs and symptoms of the disease. However, the genes themselves are <strong>not</strong> changed in such a way that these changes are passed down to an individual's children.","dateModified":"2016-06-22T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":2937,"authors":"Roger F. Butterworth","articleTitle":"Hepatic Encephalopathy","bookWebsiteJournalTitle":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","date":"September 29, 2004","volume":"","pages":"","url":"http://pubs.niaaa.nih.gov/publications/arh27-3/240-246.htm","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":524,"genericName":"Rifaximin","tradeName":"Normix","tradeLink":"","manufacturer":"","sponsor":"Salix Pharmaceuticals, Inc.","indication":"Reduction in the risk of overt hepatic encephalopathy (HE) recurrence in patients greater than or equal to 18 years of age.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=rifaximin","medlinePlusLink":""}],"EncodedName":"Hepatic_encephalopathy"}